- Global Pharma News & Resources

Small Cell Lung Cancer Therapeutics Market 2019 Trends, Size Analysis, Share, Leading Companies, Future Insights And Top Manufacturers, Forecast To 2026

Small cell lung cancer (SCLC) is a type of malignant tumor that occurs mostly in the lungs.  SCLC is characterized by a high growth rate, shorter doubling time than the non-small cell lung tumors. SCLC is more responsive to chemotherapy than NSCLC. It is caused by tobacco, unhealthy food, alcohol, HIV infected, chronic infections or family history, and physical inactivity. The symptoms of small cell lung cancer (SCLC) are dyspnea, blood in sputum, weight loss, cough, and debility.

Request Sample Copy of the Business Report:

The rising number of cancer cases projected to support the growth of small cell lung cancer therapeutics market in the near future

According to the American Cancer Society Statistics in 2016, maximum cases of SCLC occur in individuals aged 60-80 years with an estimated global death rate being 30,000 per year. Also, according to the World Health Organization (WHO), lung cancer is the second most prevailing cancer in men and women causing 1.59 million deaths in 2012. The growing prevalence of lung cancer, the unhealthy lifestyle of the individual, the introduction of innovative radiation therapies, and premium-priced drugs are expected to boost the market growth. Moreover, the growing demand for targeted therapies and platinum-based chemotherapies is projected to fuel the market growth of small lung cancer therapeutics over the forecast period. Also, improving diagnostic facilities across healthcare facilities, provision of guidelines to cancer patients by International Healthcare Organizations are further expected to propel the market growth. On the other hand, expensive treatments and lack of awareness regarding disease are expected to hamper the market growth.

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

Platinum derivatives segment accounts for the highest revenue share owing to the higher metastasis control rate

The global small cell lung cancer therapeutics market is segmented based on drug therapy, and distribution channel.

Based on drug therapy, the global small cell lung cancer therapeutics market is segmented into:

  • Targeted Therapy Drugs
  • Immunotherapy Drugs
  • Platinum Derivatives

Based on the distribution channel, the global small cell lung cancer therapeutics market is segmented into:

  • Hospital Pharmacies
  • Retail and Online Pharmacies

Enhanced health care facilities to foster the Asia Pacific small cell lung cancer market

Regional segmentation of small cell lung cancer therapeutics market by Coherent Market Insights comprises of North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. According to the American Cancer Society Statistics in 2017, around 222,500 cases of lung cancer were diagnosed with 116,990 prevailing in men and 105,510 in women, where small cell lung cancer accounts for 15 percent of lung cancers in the U.S. North America is projected to dominate the market owing to the presence of high developed regions, and improved healthcare facilities. In addition to this, Asia Pacific is projected to fuel the growth of SCLC market over the forecast period and this can be attributed to growing awareness of health care, government funding, and the presence of medical requirements for cancer therapeutics in the emerging economies such as India and China.

To understand Research Methodology, please click

Key players in the Small Cell Lung Cancer Therapeutics Market

Key players operating the small cell lung cancer therapeutics market include Bristol-Myers Squibb, GlaxoSmithKline, Menarini, Sanofi, and ZIOPHARM Oncology. 

Table of Content

Global Small Cell Lung Cancer Therapeutics Market Research Report
Section 1: Global Small Cell Lung Cancer Therapeutics Industry Overview
Section 2: Global Economic Impact on Small Cell Lung Cancer Therapeutics Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Small Cell Lung Cancer Therapeutics Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Small Cell Lung Cancer Therapeutics Market Forecast

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 11-Mar-2021